Guggenheim Capital LLC Codexis, Inc. Transaction History

Guggenheim Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$19.65 - $27.99 $354,820 - $505,415	-18,057 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$17.48 - $25.46 $57,561 - $83,839	-3,293 Reduced 15.42%	18,057 $409,000
Q1 2021 May 13, 2021	SELL	$18.08 - $28.8 $5,713 - $9,100	-316 Reduced 1.46%	21,350 $489,000
Q4 2020 Feb 16, 2021	SELL	$11.7 - $23.41 $4,750 - $9,504	-406 Reduced 1.84%	21,666 $473,000
Q3 2020 Nov 13, 2020	SELL	$11.21 - $13.82 $6,871 - $8,471	-613 Reduced 2.7%	22,072 $259,000
Q2 2020 Aug 14, 2020	SELL	$9.8 - $12.77 $6,036 - $7,866	-616 Reduced 2.64%	22,685 $259,000
Q1 2020 Jun 02, 2020	BUY	$8.78 - $18.6 $333 - $706	38 Added 0.16%	23,301 $260,000
Q4 2019 Feb 14, 2020	BUY	$13.12 - $17.06 $111,756 - $145,317	8,518 Added 57.77%	23,263 $372,000
Q3 2019 Nov 14, 2019	BUY	$12.75 - $19.01 $187,998 - $280,302	14,745 New	14,745 $202,000
Q1 2018 May 15, 2018	SELL	$8.0 - $12.8 $81,472 - $130,355	-10,184 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$5.85 - $8.4 $9,477 - $13,608	-1,620 Reduced 13.72%	10,184 $84,000
Q3 2017 Nov 14, 2017	BUY	$4.9 - $6.65 $57,839 - $78,496	11,804	11,804 $78,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.